Consuelo Amantini

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Zeppa, Cristina Aguzzi, Maria Beatrice Morelli, Oliviero Marinelli, Martina Giangrossi, Margherita Luongo, Consuelo Amantini, Giorgio Santoni, Massimo Nabissi
Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines. International journal of molecular sciences 25 (4) (2024)
Laura Zeppa, Cristina Aguzzi, Maria Beatrice Morelli, Oliviero Marinelli, Martina Giangrossi, Margherita Luongo, Consuelo Amantini, Giorgio Santoni, Massimo Nabissi
Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines. International journal of molecular sciences 25 (4) (2024)
Laura Zeppa, Cristina Aguzzi, Maria Beatrice Morelli, Oliviero Marinelli, Martina Giangrossi, Margherita Luongo, Consuelo Amantini, Giorgio Santoni, Massimo Nabissi
Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines. International journal of molecular sciences 25 (4) (2024)
Laura Zeppa, Cristina Aguzzi, Maria Beatrice Morelli, Oliviero Marinelli, Martina Giangrossi, Margherita Luongo, Consuelo Amantini, Giorgio Santoni, Massimo Nabissi
Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines. International journal of molecular sciences 25 (4) (2024)
Ilenia Martinelli, Daniele Tomassoni, Vincenzo Bellitto, Proshanta Roy, Maria Vittoria Micioni Di Bonaventura, Francesco Amenta, Consuelo Amantini, Carlo Cifani, Seyed Khosrow Tayebati
Anti-Inflammatory and Antioxidant Properties of Tart Cherry Consumption in the Heart of Obese Rats. Biology 11 (5) (2022)
Maria Beatrice Morelli, Massimo Nabissi, Consuelo Amantini, Federica Maggi, Lucia Ricci-Vitiani, Roberto Pallini, Giorgio Santoni
TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. International journal of molecular sciences 23 (23) (2022)
Laura Zeppa, Cristina Aguzzi, Giorgia Versari, Margherita Luongo, Maria Beatrice Morelli, Federica Maggi, Consuelo Amantini, Giorgio Santoni, Oliviero Marinelli, Massimo Nabissi
Evening Primrose Oil Improves Chemotherapeutic Effects in Human Pancreatic Ductal Adenocarcinoma Cell Lines-A Preclinical Study. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Maria Beatrice Morelli, Massimo Nabissi, Consuelo Amantini, Federica Maggi, Lucia Ricci-Vitiani, Roberto Pallini, Giorgio Santoni
TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. International journal of molecular sciences 23 (23) (2022)
Giorgio Santoni, Consuelo Amantini, Massimo Nabissi, Antonietta Arcella, Federica Maggi, Matteo Santoni, Maria Beatrice Morelli
Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients. International journal of molecular sciences 23 (2) (2022)
Maria Beatrice Morelli, Massimo Nabissi, Consuelo Amantini, Federica Maggi, Lucia Ricci-Vitiani, Roberto Pallini, Giorgio Santoni
TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. International journal of molecular sciences 23 (23) (2022)
Maria Beatrice Morelli, Oliviero Marinelli, Cristina Aguzzi, Laura Zeppa, Massimo Nabissi, Consuelo Amantini, Daniele Tomassoni, Federica Maggi, Matteo Santoni, Giorgio Santoni
Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines. Cancers 14 (11) (2022)
Junbiao Wang, Alessia Lamolinara, Laura Conti, Mara Giangrossi, Lishan Cui, Maria Beatrice Morelli, Consuelo Amantini, Maurizio Falconi, Caterina Bartolacci, Cristina Andreani, Fiorenza Orlando, Mauro Provinciali, Francesco Domenico Del Pizzo, Francesca Russo, Barbara Belletti, Federica Riccardo, Elisabetta Bolli, Federica Cavallo, Federica Cavallo, Augusto Amici, Manuela Iezzi, Cristina Marchini
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer. Cancers 14 (16) (2022)
Federica Maggi, Maria Beatrice Morelli, Daniele Tomassoni, Oliviero Marinelli, Cristina Aguzzi, Laura Zeppa, Massimo Nabissi, Giorgio Santoni, Consuelo Amantini
The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib. Cancer science 113 (4) (2022)
Consuelo Amantini, Federica Maggi, Jacopo Adolfo Rossi de Vermandois, Marilena Gubbiotti, Antonella Giannantoni, Ettore Mearini, Massimo Nabissi, Daniele Tomassoni, Giorgio Santoni, Maria Beatrice Morelli
The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer. Cancers 14 (13) (2022)
Giorgio Santoni, Federica Maggi, Consuelo Amantini, Antonietta Arcella, Oliviero Marinelli, Massimo Nabissi, Matteo Santoni, Maria Beatrice Morelli
Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients. International journal of molecular sciences 23 (14) (2022)
Maria Beatrice Morelli, Consuelo Amantini
Transient Receptor Potential (TRP) Channels: Markers and Therapeutic Targets for Cancer? Biomolecules 12 (4) (2022)
Giorgio Santoni, Consuelo Amantini, Federica Maggi, Oliviero Marinelli, Matteo Santoni, Maria Beatrice Morelli
The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment. Biomolecules 12 (1) (2022)
Maria Beatrice Morelli, Massimo Nabissi, Consuelo Amantini, Federica Maggi, Lucia Ricci-Vitiani, Roberto Pallini, Giorgio Santoni
TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. International journal of molecular sciences 23 (23) (2022)